Zobrazeno 1 - 10
of 620
pro vyhledávání: '"Marcoux FW"'
Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
Autor:
Feinklestein, SP, Fisher, M, Furland, AJ, Goldstein, LB, Gorelick, PB, Kaste, M, Lees, KR, Traystman, RJ, Albers, GW, Anwer, UE, Ashwood, T, Barone, FC, Basta, SL, Bogousslavsky, J, Buchan, AM, Cady, WJ, Chan, PH, Clemens, JA, Cox, BF, Craddock, RE, Cramer, SC, del Zoppo, GJ, Dielrich, WD, Elliott, P, Faden, AI, Feuerstein, GZ, Ginsberg, MD, Gold, M, Greene, WL, Hall, ED, Hsu, CY, Hunter, AJ, Lai, M, Lesko, LM, Levy, DE, Li, FH, Locke, KW, Lodge, D, Lowe, D, Marcoux, FW, McCulloch, J, McDermott, J, Meibach, R, Messersmith, EK, Moseley, M, Moskowitz, MA, Mueller, AL, Munro, F, Nudo, RJ, Oeda, J, Ohlstein, EH, Parsons, A, Patmore, L, Poole, RM, Pschorn, U, Pulsinelli, WA, Sacco, RL, Saeki, S, Salazar-Grueso, E, Sandage, BW, Schallert, T, Schielke, GP, Sharkey, J, Sotak, CH, Steiger, B, Storall, S, Takahashi, Y, Tumas, D, Van Bruggen, N, Versavel, M, Vornov, J, Walker, MD, Wallin, B, Wang, J, Warach, S, Wells, DS, Witcher, JA, Round, STAI
Publikováno v:
Europe PubMed Central
Abstract —The plethora of failed clinical trials with neuroprotective drugs for acute ischemic stroke have raised justifiable concerns about how best to proceed for the future development of such interventions. Preclinical testing of neuroprotectiv
Autor:
Hladky, Stephen B.1 (AUTHOR) sbh1@cam.ac.uk, Barrand, Margery A.1 (AUTHOR)
Publikováno v:
Fluids & Barriers of the CNS. 6/10/2024, Vol. 21 Issue 1, p1-33. 33p.
Autor:
Blair CM; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Portage Glasgow Limited, Glasgow, UK., Walsh NM; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Littman BH; Portage Pharmaceuticals Limited, Tortola, British Virgin Islands.; EyGen Inc, Wilmington, DE, USA., Marcoux FW; Portage Glasgow Limited, Glasgow, UK.; Portage Pharmaceuticals Limited, Tortola, British Virgin Islands., Baillie GS; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. George.Baillie@glasgow.ac.uk.; Portage Glasgow Limited, Glasgow, UK. George.Baillie@glasgow.ac.uk.
Publikováno v:
BMC cancer [BMC Cancer] 2019 Mar 25; Vol. 19 (1), pp. 266. Date of Electronic Publication: 2019 Mar 25.
Autor:
Kikuchi, Kazufumi1 (AUTHOR) kikuchi.kazufumi.953@m.kyushu-u.ac.jp, Togao, Osamu1 (AUTHOR), Yamashita, Koji2 (AUTHOR), Isoda, Takuro2 (AUTHOR), Nishimura, Ataru3 (AUTHOR), Arimura, Koichi3 (AUTHOR), Nakamizo, Akira3 (AUTHOR), Yoshimoto, Koji3 (AUTHOR), Ishigami, Kousei2 (AUTHOR)
Publikováno v:
Scientific Reports. 3/5/2024, Vol. 14 Issue 1, p1-9. 9p.
Autor:
Montezano, Augusto C.1,2 (AUTHOR) augusto.montezano@muhc.mcgill.ca, Camargo, Livia L.1 (AUTHOR), Mary, Sheon2 (AUTHOR), Neves, Karla B2,3 (AUTHOR), Rios, Francisco J1 (AUTHOR), Stein, Ross2 (AUTHOR), Lopes, Rheure A.2 (AUTHOR), Beattie, Wendy2 (AUTHOR), Thomson, Jacqueline2 (AUTHOR), Herder, Vanessa4 (AUTHOR), Szemiel, Agnieszka M.4 (AUTHOR), McFarlane, Steven4 (AUTHOR), Palmarini, Massimo4 (AUTHOR), Touyz, Rhian M.1,2,5 (AUTHOR) rhian.touyz@mcgill.ca
Publikováno v:
Scientific Reports. 11/20/2023, Vol. 13 Issue 1, p1-13. 13p.
Autor:
Probert AW; Department of Neurological and Neurodegenerative Diseases, Parke-Davis Research Division, Warner-Lambert Company, Ann Arbor, MI 48105, U.S.A., Borosky S, Marcoux FW, Taylor CP
Publikováno v:
Neuropharmacology [Neuropharmacology] 1997 Aug; Vol. 36 (8), pp. 1031-8.
Autor:
Wang KK; Department of Neuroscience Therapeutics, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA., Nath R, Posner A, Raser KJ, Buroker-Kilgore M, Hajimohammadreza I, Probert A W Jr, Marcoux FW, Ye Q, Takano E, Hatanaka M, Maki M, Caner H, Collins JL, Fergus A, Lee KS, Lunney EA, Hays SJ, Yuen P
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 1996 Jun 25; Vol. 93 (13), pp. 6687-92.
Autor:
Wang KK; Department of Neuroscience Therapeutics, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan 48105, USA., Posner A, Raser KJ, Buroker-Kilgore M, Nath R, Hajimohammadreza I, Probert AW, Marcoux FW, Lunney EA, Hays SJ, Yuen P-W
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 1996; Vol. 389, pp. 95-101.
Autor:
Hajimohammadreza I; Department of Neuroscience Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105, USA., Probert AW, Coughenour LL, Borosky SA, Marcoux FW, Boxer PA, Wang KK
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 1995 May; Vol. 15 (5 Pt 2), pp. 4093-101.
Autor:
Birrell GJ; Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI 48106-1047., Gordon MP, Marcoux FW
Publikováno v:
Neuropharmacology [Neuropharmacology] 1993 Dec; Vol. 32 (12), pp. 1351-8.